These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24623414)

  • 1. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
    Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
    J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Matrix Protein p17 and its Receptors.
    Caccuri F; Marsico S; Fiorentini S; Caruso A; Giagulli C
    Curr Drug Targets; 2016; 17(1):23-32. PubMed ID: 26302809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.
    Caccuri F; Giagulli C; Bugatti A; Benetti A; Alessandri G; Ribatti D; Marsico S; Apostoli P; Slevin MA; Rusnati M; Guzman CA; Fiorentini S; Caruso A
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14580-5. PubMed ID: 22904195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.
    Giagulli C; Marsico S; Magiera AK; Bruno R; Caccuri F; Barone I; Fiorentini S; Andò S; Caruso A
    PLoS One; 2011 Mar; 6(3):e17831. PubMed ID: 21423810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
    Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A
    Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
    J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity.
    Giagulli C; Caccuri F; Cignarella F; Lougaris V; Martorelli D; Bugatti A; Rusnati M; Dolcetti R; Vitali M; Plebani A; Fiorentini S; Caruso A
    AIDS; 2014 Oct; 28(16):2355-64. PubMed ID: 25121556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
    Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.
    Depienne C; Roques P; Créminon C; Fritsch L; Casseron R; Dormont D; Dargemont C; Benichou S
    Exp Cell Res; 2000 Nov; 260(2):387-95. PubMed ID: 11035935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
    Giagulli C; D'Ursi P; He W; Zorzan S; Caccuri F; Varney K; Orro A; Marsico S; Otjacques B; Laudanna C; Milanesi L; Dolcetti R; Fiorentini S; Lu W; Caruso A
    Sci Rep; 2017 Jul; 7(1):6555. PubMed ID: 28747658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
    Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
    J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.
    Renga B; Francisci D; Schiaroli E; Carino A; Cipriani S; D'Amore C; Sidoni A; Sordo RD; Ferri I; Lucattelli M; Lunghi B; Baldelli F; Fiorucci S
    PLoS One; 2014; 9(4):e94798. PubMed ID: 24736615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Dolcetti R; Giagulli C; He W; Selleri M; Caccuri F; Eyzaguirre LM; Mazzuca P; Corbellini S; Campilongo F; Marsico S; Giombini E; Muraro E; Rozera G; De Paoli P; Carbone A; Capobianchi MR; Ippolito G; Fiorentini S; Blattner WA; Lu W; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14331-6. PubMed ID: 26578780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.
    González SA; Affranchino JL; Gelderblom HR; Burny A
    Virology; 1993 Jun; 194(2):548-56. PubMed ID: 8503172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.
    Bugatti A; Giagulli C; Urbinati C; Caccuri F; Chiodelli P; Oreste P; Fiorentini S; Orro A; Milanesi L; D'Ursi P; Caruso A; Rusnati M
    J Biol Chem; 2013 Jan; 288(2):1150-61. PubMed ID: 23166320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.
    Morikawa Y; Zhang WH; Hockley DJ; Nermut MV; Jones IM
    J Virol; 1998 Sep; 72(9):7659-63. PubMed ID: 9696871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
    González SA; Affranchino JL
    Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.